Song Ruilin, executive chairman of the China Association for the promotion of drugs, meets with the president of the American Cancer Research Foundation and his delegation

Source: on October 30, 2017-11-01, at the second China Pharmaceutical Innovation and Investment Conference (hereinafter referred to as "the conference"), song Ruilin, executive chairman of China Pharmaceutical Innovation Promotion Association (hereinafter referred to as "China pharmaceutical promotion association"), met with the American Cancer Research Foundation (hereinafter referred to as "the foundation") in Suzhou Joseph franlin, chairman of cancer research (NFCR), Sujuan Ba, President and chief operating officer, Michael Wang, Chief Strategic Officer, Bradley Gillenwater, senior manager of global project communication, Charlie weatherspoon, consultant of the board of directors, William werkmeister, media consultant, and other parties have conducted in-depth exchanges and reached many consensus on promoting pharmaceutical R & D and innovation cooperation between China and the United States Joseph President franlin expressed his thanks for the warm reception and highly praised the success of the second China Pharmaceutical Innovation and investment conference He said that the conference has set up a good communication and cooperation platform for all parties, promoted the cooperation and exchanges between all parties to be more in-depth and pragmatic, and looked forward to further and multi-faceted cooperation with China pharmaceutical promotion conference in the future 。 Song Ruilin, executive chairman of the foundation, expressed warm welcome and sincere thanks for the coming of the foundation, congratulated on the success of the US cancer drug roadshow, and expressed that the cooperation between the two conferences has a very positive meaning for deepening the mutual understanding and cooperation between the pharmaceutical research and development circles of the two countries The pharmaceutical research and development and innovation circles of the two countries have every reason to work together to overcome cancer Breakthrough point: establish cooperation mechanism to jointly promote global pharmaceutical innovation Dr Ba gave a detailed introduction to the next work and projects of the foundation, and hoped to establish a cooperation working group with the China Council for the promotion of drugs, in order to build an innovation platform for cancer medicine between China and the United States, and further promote the exchanges and cooperation between the two conferences in scientific research, clinical, industrial and policy fields Ding liming, annual president of China Association for the promotion of drugs, chairman and CEO of Beida Pharmaceutical Co., Ltd., Yang Dajun, vice chairman of drug R & D special committee of China Association for the promotion of drugs, chairman and CEO of Jiangsu Yasheng Pharmaceutical Development Co., Ltd., Li Wenbin, vice chairman of drug clinical research professional committee of China Association for the promotion of drugs and director of brain glioma Department of Beijing Shijitan Hospital Lu Xiaoti, director of the International Department of the China Association for the promotion of drugs, attended the meeting Conference site